Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A participant or their legal representative has agreed to take part by signing a consent form
- The person is over 18 years of age
- The person has advanced heart failure with severe symptoms (classified as Stage III or IV), has a mild leaky tricuspid heart valve (a valve on the right side of the heart), and is already scheduled to receive a surgically implanted heart assist device called an LVAD
Who may not be able to join:
- The person has previously had repair surgery on their tricuspid heart valve
- There is evidence of physical damage to the structure of the tricuspid valve, such as problems with the cords or flaps of the valve
- There are technical surgical obstacles that the investigator considers to carry an unusually high risk (confirm with trial site)
- The person is already using a mechanical heart support device, other than a specific type called an intra-aortic balloon pump
- The person has a Body Mass Index (a measure of body weight relative to height) above 45
- The person is pregnant
- The person has a mechanical aortic heart valve that will not be replaced with a tissue-based valve at the time of LVAD surgery
- The person has previously had a heart transplant or a procedure called cardiomyoplasty (a surgery involving muscle wrapped around the heart)
- The person has a psychiatric illness, significant memory or thinking difficulties, or social circumstances that are likely to make it hard to follow the study requirements and manage the LVAD device
- The person has an active infection that is not under control
- The person has evidence of liver disease, based on liver enzyme blood test results
- The person has had a stroke in the 90 days before enrolling, or has a history of significant narrowing (more than 80%) of blood vessels leading to the brain
- The person requires ongoing kidney dialysis
- The person is already taking part in another clinical trial that could interfere with this study's results
- The person has a condition other than heart failure that is likely to limit survival to less than one year
- The person does not wish to take part in the study
- The person is currently living in an institutional facility as an inmate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kei Togashi, MD, MPH, University of Washington
Phone: 206-616-1893
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in TR severity assessment from baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.